Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study

• Wei Lee,
• Caitlin Sheehan,
• Richard Chye,
• Sungwon Chang,
• Adam Bayes,
• Colleen Loo,
• Brian Draper,
• Meera R. Agar,
• David C. Currow

Affiliations

Wei Lee

Caitlin Sheehan

Richard Chye

Sungwon Chang

Adam Bayes

Colleen Loo

Brian Draper

Meera R. Agar

David C. Currow